Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2022年7月1日
	新闻
	AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial By Reuters Investing.com Non-small cell lung cancer is the most common form of lung cancer, accounting for about 85% of the estimated 2.2 million new cases of the disease ... 标记为不相关
	Global Pulmonology Lasers Market to Grow with a CAGR of ~12% During 2022-2031 - News Azi News Azi New York, June 30, 2022 (GLOBE NEWSWIRE) — In the United States, between 10% to 20% of lung cancer cases, or 20,000 to 40,000 cases each year, ... 标记为不相关
	Zandelisib Displays "Exemplary" Efficacy in Relapsed/Refractory Follicular Lymphoma Cancer Therapy Advisor Factors Associated With Non-Small Cell Lung Cancer Stage at PresentationVicki Moore, ... 1 case of pneumonia, and 1 case of tumor lysis syndrome. 标记为不相关
	The top five private biotech companies in China - Labiotech Labiotech Avistone is developing a pipeline of small molecule drugs for lung cancer, with its lead candidate in late-stage clinical trials for the treatment ... 标记为不相关
	What Construction Employers Need to Know About the Increased Silica Compliance Focus JD Supra ... including silicosis (an incurable but preventable lung disease), as well as increased risk for lung cancer and kidney disease. 标记为不相关
	Mark Patrick Wirkes Obituary - Appleton - The Post-Crescent The Post-Crescent Mark Patrick Wirkes (Marcus Aurelius, Spartan-at-Large) passed away on June 25, 2022 after a short battle with lung cancer. We thought we would... 标记为不相关
	M18-868: Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab ... Avera Health ... in Subjects with Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈